Hypoxia-induced CXCL8 in ESCA recruits MDSCs and upregulates PD-L1, paralleling its role in melanoma and CRC, where CXCL8 drives neutrophil/MDSC recruitment and angiogenesis, underpinning anti-PD-1 resistance. Here, CXCL8 is linked to colorectal carcinoma.